DNA glycosylase composition and application thereof
By constructing a DNA glycosylase composition that does not rely on deaminase, high precision G-to-Y base editing of the mitochondrial genome is achieved, and the difficulty of non-target editing and vector delivery caused by deaminase in the prior art is solved. Problem, expanding the application scope of base editor.
Patent Information
- Application Number
- CN202410956946.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-16
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2044-07-16
AI Technical Summary
Existing mitochondrial genome editing technologies face the difficulty of non-target base editing and vector delivery caused by deaminase, and lack a high-precision mitochondrial base editor that does not rely on deaminase.
Develop a DNA glycosylate enzyme composition, including transport peptides, TALE arrays, DNA nickases and guanine DNA glycosylate enzymes, to build a mitochondrial guanine base editor that does not rely on deaminase to achieve G base Selective editing of DNA strands.
It improves the accuracy and efficiency of base editing, reduces the technical difficulty of the editor to the target cells, avoids off-target effects caused by deaminase, and is suitable for G-to-Y base editing of the mitochondrial genome of eukaryotic organisms.
Smart Images

Figure CN118995665A_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the technical field of base editors, and in particular to a DNA glycosylase composition and its application. Background Art
[0002] Mitochondria are the energy and metabolic centers of cells, playing a key role in catabolism, respiration, regulation of cell signaling pathways, and apoptosis. Mitochondria are semi-autonomous organelles that contain their own genomic DNA (mtDNA). Human mtDNA generally has 2 to 10 copies per cell. Each mtDNA is about 16.5kb long and contains 37 genes, encoding 12S rRNA, 16S rRNA, 22 tRNAs, and 13 proteins. The mitochondrial genome size of plants is generally between 66Kb and 11Mb, containing 50 to 60 genes, and is inherited from a single parent. In comparison, plant mtDNA is much larger than that of other eukaryotic organisms, and its structure evolves rapidly.
[0003] Due to reactive oxygen and other reasons, the mutation rate of human mtDNA is two orders of magnitude higher than that of nuclear DNA, and mtDNA mutations will lead to mitochondrial ATP synthesis disorders, insufficient cell energy supply, metabolic enzyme defects, and thus body dysfunction. Dozens of genetic diseases such as mitochondrial myopathy are known to be associated with mtDNA mutations. In plants, mtDNA genetic information affects important agronomic traits, including fertility, plant vigor, chloroplast function, and hybrid compatibility. Editing and modifying mtDNA sequences has important practical significance, whether for repairing human mtDNA mutations, achieving treatment of diseases caused by mitochondrial mutations, or modifying plant mtDNA genes to achieve important agronomic trait improvements.
[0004] In recent years, genome editing technology has been rapidly updated and iterated, and genome editing technologies such as base editing and prime editing have been developed. Base editors can achieve high-efficiency and high-precision single nucleotide replacement, and are usually composed of DNA binding modules and DNA modification enzymes. The DNA binding module is generally a Cas nickase (such as Cas9 D10A nickase) or a transcription activator-like effector (TALE) array. The DNA binding module carries a DNA modification enzyme to target the DNA target site, and then the DNA modification enzyme modifies the target site sequence, and finally obtains the genetic variation of interest. According to the type of DNA modification enzyme, two types of base editors have been developed: deaminase-based base editors (dBE) and deaminase-free glycosylase-based base editors (gBE). dBE uses single-stranded or double-stranded DNA deaminases for base editing, including adenine base editors (ABE), cytosine base editors (CBE), and DddA-derived cytosine base editors (DdCBE), as well as their derivative systems (A&C-BEmax, AYBE, AXBE, and CGBE, etc.). gBE uses glycosylases for base editing, including deaminase-free glycosylase-based thymine base editors (gTBE), deaminase-free glycosylase-based cytosine base editors (gCBE), etc.
[0005] Limited by the particularity of the mitochondrial membrane and mtDNA repair mechanism, mitochondrial genome editing technology faces many difficulties, and base editors suitable for the mitochondrial genome are relatively scarce. For example, the CRISPR / Cas gene editing system, which is widely used in nuclear genomes, is difficult to use CRISPR / Cas to edit the mitochondrial genome because its guide RNA (gRNA) component is difficult to deliver to the mitochondria of eukaryotic organisms. At present, mitochondrial genome base editors are composed of transcription activator-like effector (TALE) arrays fused with DNA modification enzymes, including DdCBE and CyDENT cytosine base editors, TALED adenine base editors, and mitoBEs mitochondrial DNA base editors. They are all deaminase-based adenine and cytosine base editors. It is reported that deaminases can cause a large number of off-target mutations in cellular DNA and RNA; although deaminases are connected to Cas proteins or TALE arrays, deaminases may act on chromosomal DNA and induce non-target base editing. Therefore, the development of a mitochondrial base editing system without deaminases is of great practical significance.
[0006] A recent paper reported a guanine base editor (gGBE) based on a deaminase-free glycosylase, which can directly edit the G base and show high base editing efficiency (up to 81%) in both mice and cultured human cells. The G-to-T / C (i.e., G-to-Y) conversion rate in embryos is also as high as 95%, and the G to T base conversion is achieved in transgenic rice plants with an efficiency of 39.1%. The gGBE was developed by fusing the Cas9 nickase (nCas9) with an engineered N-methylpurine DNA glycosylase protein (MPG) mutant. Since the guide RNA (gRNA) of the Cas9 nickase is difficult to deliver to the mitochondria of eukaryotes, this makes gGBE unable to be used in mitochondrial base editing. A research team reported the use of the cytosine deaminase DddA E1347A Mutants and MPG established a mitochondrial genome guanine base editor. However, the mitochondrial editor still used the inactivated cytosine deaminase DddA E1347A Mutants, and the editor edits all G bases in the double-stranded DNA of the target site instead of editing a specific single strand.
[0007] In summary, in order to avoid non-target base editing that may be introduced by deaminases, improve the accuracy of base editing, and reduce the difficulty of vector delivery technology, the development of a deaminase-independent, DNA-chain-selective, compact mitochondrial genome guanine base editor remains a research focus and difficulty in the field of base editor technology. Summary of the invention
[0008] The purpose of the present application is to provide a new DNA glycosylase composition, an expression vector for expressing the DNA glycosylase composition, and the application of the DNA glycosylase composition and the expression vector.
[0009] This application adopts the following technical solutions:
[0010] The first aspect of the present application discloses a DNA glycosylase composition, which is a monomeric fusion protein or a dimeric fusion protein; the monomeric fusion protein sequentially fuses a transit peptide, a DNA exonuclease, a TALE array, a DNA nickase, and a guanine DNA glycosylase; the dimeric fusion protein includes an L fusion protein and an R fusion protein, wherein the L fusion protein sequentially fuses a transit peptide, a TALE-L, a DNA nickase, and a DNA exonuclease, and the R fusion protein sequentially fuses a transit peptide, a TALE-R, and a guanine DNA glycosylase; the transit peptide is used to guide the guanine base editor to the corresponding organelle to achieve the editing of the G base; the TALE array, TALE-L, and TALE-R are all composed of an N-terminal functional domain, a repeating unit array, and a C-terminal functional domain, wherein the repeating unit array is a specific binding sequence designed for a target sequence. Among them, the TALE array in the monomeric fusion protein is usually the TALE-L in the L fusion protein of the dimeric fusion protein.
[0011] It should be noted that the DNA glycosylase composition of the present application creatively combines transit peptides, TALE arrays with engineered guanine DNA glycosylase (abbreviated GDG), DNA nickases, and DNA exonucleases, so that the constructed glycosylase composition can be used for base editing of guanine in the mitochondrial genomes of various animals and plants. The DNA glycosylase composition of the present application is used for mitochondrial genome guanine editing. First, it does not rely on deaminases, avoiding non-target editing that may be caused by deaminases; second, its G base editing has DNA chain selectivity, which increases the accuracy of base editing. Third, the compact single fusion protein provided by the present application is used as a G base editor, which reduces the technical difficulty of delivering the base editor to the target cell.
[0012] It should also be noted that the DNA glycosylase composition of the present application is independent of deaminase and has high editing efficiency and low off-target effects. It is particularly suitable for the guanine base editor system of the genome of eukaryotic organelles such as mitochondria, and realizes base editing of organelle genomes from G to Y, that is, G to T or G to C, avoiding the off-target effects that may be caused by deaminase and improving the accuracy of G base editing.
[0013] It can be understood that the DNA glycosylase composition of the present application, first, uses transit peptides and TALE arrays to guide the base editor into the target site of the organelle genome; secondly, avoids the use of deaminases to reduce the possible off-target effects caused by deaminases; thirdly, uses DNA nickases and engineered guanine DNA glycosylases to achieve G to Y base editing of the organelle genome, enriching the technical means of base editing of the organelle genome of higher organisms. When the glycosylase composition established in this application is used as a guanine base editor system, on the one hand, it can be applied to the study of organelle gene functions in animals, plants and human cells, and on the other hand, it can also be applied to agricultural biological breeding scenarios such as modifying crop organelle genes to improve agronomic traits.
[0014] In one implementation of the present application, the transit peptide of the monomeric fusion protein and the dimeric fusion protein is a plant mitochondrial transit peptide or an animal mitochondrial transit peptide.
[0015] It can be understood that when the transit peptide is a plant mitochondrial transit peptide, the DNA glycosylase composition of the present application is a guanine base editor targeting the plant mitochondrial genome; when the transit peptide is an animal mitochondrial transit peptide, the DNA glycosylase composition of the present application is a guanine base editor targeting the animal mitochondrial genome.
[0016] In one implementation of the present application, the plant mitochondrial transit peptide is derived from the rice Rf1b cytoplasmic male sterility restorer gene transit peptide.
[0017] In one implementation of the present application, the animal mitochondrial transit peptide is a human mitochondrial transit peptide, which is a mitochondrial transit peptide derived from the human COX8A gene.
[0018] In one implementation of the present application, the plant mitochondrial transit peptide is the sequence shown in SEQ ID NO.1.
[0019] In one implementation of the present application, the animal mitochondrial transit peptide is the sequence shown in SEQ ID NO.2.
[0020] It should be noted that the key to this application is to creatively combine transit peptides, TALE arrays with engineered GDG, DNA nickase and DNA exonuclease to construct a base editing system for guanine in the genome of organelles of higher organisms; the specific transit peptides of the sequences shown in SEQ ID NO.1 and SEQ ID NO.2 are only transit peptide sequences specifically used in one implementation of this application. It can be understood that under the inventive concept of this application, transit peptides of other specific sequences can also be used, and no specific limitation is made here.
[0021] In one implementation of the present application, the N-terminal functional domain of the monomeric fusion protein and the dimeric fusion protein is the sequence shown in SEQ ID NO.3.
[0022] In one implementation of the present application, the C-terminal functional domain of the monomeric fusion protein and the dimeric fusion protein is the sequence shown in SEQ ID NO.4.
[0023] It should be noted that in the TALE array, the N-terminal functional domain (NTD) and the C-terminal functional domain (CTD) are fixed amino acid sequences, such as the sequences shown in SEQ ID NO.3 and SEQ ID NO.4; the repeat unit array is designed and assembled according to the sequence of the target editing site, and the repeat unit array is assembled using the Golden Gate method, and a commercial company can be entrusted to assemble the TALE repeat units. It can be understood that the sequences shown in SEQ ID NO.3 and SEQ ID NO.4 are only the N-terminal functional domain and C-terminal functional domain specifically used in one implementation of the present application. Those skilled in the art can refer to the prior art to adjust the specific sequence, and no specific limitation is made here.
[0024] In one implementation of the present application, the DNA nickase of the monomeric fusion protein and the dimeric fusion protein is BspD6I nickase, MutH nickase or Fok1-Fok1 D450A Nicking enzyme.
[0025] In one implementation of the present application, the BspD6I nickase is the sequence shown in SEQ ID NO.5.
[0026] In one implementation of the present application, the MutH nickase is the sequence shown in SEQ ID NO.6.
[0027] In one implementation of the present application, Fok1-Fok1 D450A The nicking enzyme is the sequence shown in SEQ ID NO.7.
[0028] In one implementation of the present application, the DNA exonuclease of the monomeric fusion protein and the dimeric fusion protein is Trex2 exonuclease or mExoI exonuclease.
[0029] In one implementation of the present application, the Trex2 exonuclease is the sequence shown in SEQ ID NO.8.
[0030] In one implementation of the present application, the mExoI exonuclease is the sequence shown in SEQ ID NO.9.
[0031] In one implementation of the present application, the DNA exonuclease of the monomeric fusion protein is connected to the TALE array via a 48aa linker.
[0032] In one implementation of the present application, the 48aa linker is the sequence shown in SEQ ID NO.10.
[0033] In one implementation of the present application, the DNA nickase and guanine DNA glycosylase of the monomeric fusion protein are connected via a 16aa linker.
[0034] In one implementation of the present application, the DNA nickase and the DNA exonuclease of the L fusion protein are connected via a 16aa linker.
[0035] In one implementation of the present application, the 16aa linker is the sequence shown in SEQ ID NO.11.
[0036] It should be noted that BspD6I nickase, MutH nickase, Fok1-Fok1 D450A Nicking enzyme, Trex2 exonuclease, mExoI exonuclease are just DNA nicking enzymes and DNA exonucleases with high editing efficiency specifically used in one implementation of the present application; it can be understood that on this basis, other known DNA nicking enzymes and DNA exonucleases can also be used. Similarly, the connection sequence between the DNA nicking enzyme and the DNA exonuclease can also be adjusted with reference to the prior art, not limited to the 48aa linker of the sequence shown in SEQ ID NO.10 or the 16aa linker of the sequence shown in SEQ ID NO.11.
[0037] In one implementation of the present application, guanine DNA glycosylase is an engineered mutant of gMPGV6.3, and its mutation information is G163R, N169G, D175R, C178N, S198A, K202A, G203A, S206A, K210A and K294R.
[0038] In one implementation of the present application, the guanine DNA glycosylase is the sequence shown in SEQ ID NO.12.
[0039] It should be noted that the engineered mutants of gMPGV6.3 can refer to the literature: Programmable deaminase-free base editors for G-to-Y conversion by engineered glycosylase https: / / doi.org / 10.1093 / nsr / nwad143. The key to this application is to creatively combine the engineered guanine DNA glycosylase with the transit peptide, TALE array, DNA nickase and DNA exonuclease to construct the glycosylase composition of this application for guanine base editing; it can be understood that under the inventive concept of this application, it is not excluded that other engineered guanine DNA glycosylases with the same or similar functions can also be used, and no specific limitation is made here.
[0040] The second aspect of the present application discloses an expression vector for expressing the DNA glycosylase composition of the present application.
[0041] It can be understood that when the DNA glycosylase composition of the present application is a binary fusion protein, the two fusion proteins, L fusion protein and R fusion protein, are expressed separately, i.e., a vector expressing the L fusion protein and a vector expressing the R fusion protein. Of course, other ways of expressing the DNA glycosylase composition of the present application are not excluded.
[0042] In one implementation of the present application, when the DNA glycosylase composition is used for base editing of plant organelles, the transit peptide is a plant mitochondrial transit peptide, and the expression vector is driven by a rice Ubi promoter (rUbi) and / or a corn Ubi promoter (ZmUbi); when the DNA glycosylase composition is used for base editing of animal organelles, the transit peptide is an animal mitochondrial transit peptide, and the expression vector is driven by the human elongation factor EF-1α core promoter.
[0043] It should be noted that the DNA glycosylase composition of the present application can be used for mitochondrial genome editing of plants or for mitochondrial genome editing of animals, depending on the specific transit peptide used. It can be understood that the promoters specifically used in the two expression vectors are different for plants and animals. The rice Ubi promoter and the corn Ubi promoter are only promoters specifically used for plant expression vectors in one implementation of the present application, and other promoters that can be applied to plant expression vectors are not excluded. Similarly, the human elongation factor EF-1α core promoter is also only a promoter specifically used for animal expression vectors in one implementation of the present application, and other promoters that can be applied to animal expression vectors are not excluded.
[0044] In one implementation of the present application, the expression vector has a replicon that propagates in Escherichia coli and / or Agrobacterium.
[0045] In one implementation of the present application, the expression vector has a selection marker.
[0046] In one implementation of the present application, the selection marker is a kanamycin resistance gene or an ampicillin resistance gene.
[0047] The third aspect of the present application discloses the use of the DNA glycosylase composition of the present application or the expression vector of the present application in the preparation of reagents for mitochondrial genome editing.
[0048] The fourth aspect of the present application discloses the use of the DNA glycosylase composition of the present application or the expression vector of the present application in the preparation of breeding reagents or gene therapy reagents.
[0049] It should be noted that the DNA glycosylase composition or expression vector of the present application can achieve guanine base editing of the genome of organelles such as plant mitochondria or animal mitochondria, that is, to achieve base editing from G to T or G to C; therefore, it can not only be used to prepare mitochondrial genome editing reagents, for example, as a mitochondrial genome editor; it can also be used for organelle gene function research in plant, animal and human cells, for modifying crop organelle genes to improve agronomic traits and other agricultural biological breeding, as well as gene therapy based on base editing, etc.
[0050] It should also be noted that the guanine base editing system based on the DNA glycosylase composition of the present application provides technical support for the clinical treatment of related mitochondrial diseases and repairs the mtDNA mutations that cause mitochondrial diseases, such as (1) Leigh syndrome, which often occurs in childhood, with symptoms of motor retardation, symptoms and signs of brainstem and / or basal ganglia involvement, and prone to respiratory failure; it can also be late-onset, with cerebellar ataxia, dementia, hearing loss, vision loss, and cardiomyopathy, which is caused by the mtDNA mutation m.8993T>G. (2) Neurogenic myasthenia, ataxia, and retinitis pigmentosa (NARP), which often starts in childhood to early adulthood, causes myopathy, peripheral neuropathy, ataxia, pigmentary retinopathy, epilepsy, dementia, and may also cause migraine and mental retardation, which is caused by the mtDNA mutation m.8993T>G / C. (3) Myoclonic epilepsy with ragged red fibers (MERRF), a disease phenotype associated with epilepsy, often accompanied by ataxia, with the phenotypes of myoclonic epilepsy and ragged red fibers, usually caused by mutations in the mtDNA gene encoding lysine tRNA. About 90% of MERRF is caused by mutations in the MT-TK gene m.8344A>G, m.8356T>C, m.8363G>A and m.8361G>A.
[0051] The beneficial effects of this application are:
[0052] The DNA glycosylase composition of the present application, when used for guanine base editing of plant or animal mitochondrial genomes, firstly, does not rely on deaminases, thus avoiding non-target editing caused by deaminases; secondly, mitochondrial genome G base editing has DNA chain selectivity, which increases the accuracy of base editing; thirdly, the compact single fusion protein serves as a G base editor, which reduces the technical difficulty of delivering the base editor to the target cells. BRIEF DESCRIPTION OF THE DRAWINGS
[0053] Figure 1 This is a schematic diagram of the glycosylase composition used as a guanine base editor for the organelle genome and its working principle in the embodiments of the present application;
[0054] Figure 2This is a schematic diagram of the structure of the supporting expression vector of the plant gMtGBE system in the embodiment of the present application;
[0055] Figure 3 It is a schematic diagram of the structure of the supporting expression vector of the human gMtGBE system in the examples of this application. DETAILED DESCRIPTION
[0056] In order to avoid non-target base editing that may be introduced by deaminases, improve the accuracy of base editing, and reduce the technical difficulty of vector delivery, the purpose of this application is to establish a mitochondrial genome guanine base editor with high editing efficiency and low off-target effects, suitable for eukaryotic mitochondrial genomes, independent of deaminases, with DNA chain selectivity, and compact structure, to achieve base editing of organelle genomes from G to Y (i.e., G to T or G to C). This base editing system does not rely on deaminases, avoids non-target editing that may be caused by deaminases, and has the DNA chain selectivity of base editing, improving the accuracy of base editing. (1) DNA nickase and engineered guanine-DNA glycosylase (GDG) as well as transit peptides and TALE display peptides are used to form functional complexes to achieve G to Y base editing of the mitochondrial genome, avoiding the use of deaminases and reducing possible off-target effects caused by deaminases; (2) Nickase and exonuclease are used to produce strand-selective DNA nicks and exposed single strands to achieve DNA strand-selective G to Y base editing, shorten the target site editing interval, and increase the accuracy of base editing; (3) A G base editor with a compact single fusion protein is established to reduce the technical difficulty of delivering the base editor to the target cells.
[0057] The present application establishes a guanine base editor that is applicable to the mitochondrial genome of eukaryotes, is independent of deaminase, and has DNA chain selectivity, that is, the DNA glycosylase composition of the present application. The DNA glycosylase composition of the present application, namely the guanine base editor, is named glycosylase-based Mitochondia Guanine Base Editor (gmtGBE). gmtGBE contains the following key components: transit peptide, TALE array, nickase, exonuclease and guanine-DNA glycosylase (GDG), such as Figure 1As shown. According to the combination pattern of the above components, the glycosylase composition can be divided into a dimeric fusion protein and a monomeric fusion protein pattern. The dimeric fusion protein (i.e., dimeric gmtGBE) is composed of an L fusion protein and an R fusion protein, while the monomeric fusion protein (monomeric gmtGBE) is a single fusion protein. The dimeric gmtGBE is composed of an L fusion protein that sequentially fuses a transit peptide, a TALE-L array, a nickase, and an exonuclease component, and the R fusion protein that sequentially fuses a transit peptide, a TALE-R array, and a GDG component. The monomeric gmtGBE sequentially fuses a transit peptide, an exonuclease, a TALE array, a nickase, and a GDG component, as shown. Figure 1 shown.
[0058] The basic working principle of gmtGBE described in this application is: the nickase, exonuclease and GDG components are carried into the mitochondria by the transit peptide and TALE array and positioned at the base editing target site; the nickase is fused with the TALE to recognize one of the double-stranded DNA chains at the target site, cut the chain and produce a nick, and has chain selectivity; the exonuclease recognizes the nick region and digests the nicked DNA chain, thereby forming an exposed short single-stranded DNA (ssDNA) fragment on the other chain; GDG uses ssDNA as a substrate to remove the G base at the target editing site to generate an apyrimidine or apurinic (AP) site, and the AP site will be repaired by translesion synthesis (TLS) and / or DNA replication, resulting in base editing from G to Y, such as Figure 1 shown.
[0059] The function of the transit peptide in the gmtGBE fusion protein is to guide the base editor into the mitochondria. The present application provides two transit peptides. According to two application scenarios, such as targeting plant mitochondria and human mitochondrial genomes, the corresponding transit peptides are selected, that is, plant mitochondrial transit peptides are selected when the plant mitochondrial genome is targeted for editing, and human mitochondrial transit peptides are selected when the human and animal mitochondrial genomes are targeted for editing. The plant mitochondrial transit peptide is derived from the rice Rf1b cytoplasmic male sterility restorer gene transit peptide, and the human mitochondrial transit peptide is derived from the mitochondrial transit peptide of the human COX8A gene. It is worth noting that the selection of transit peptides is not limited to the two types provided above, and other transit peptides with mitochondrial localization functions can also be selected.
[0060] The function of the TALE array in the gmtGBE fusion protein is to accurately carry components such as nickase, exonuclease and GDG to the target editing site of the genome. Since the gRNA component of CRISPR / Cas9 cannot enter the organelle, and TALE can enter the organelle under the guidance of the signal peptide and accurately locate the target editing site of the organelle genome, this application uses the TALE array as the DNA binding domain component. TALE consists of three parts: the N-terminal functional domain (NTD), the repeat unit array and the C-terminal functional domain (CTD). The N-terminal functional domain (NTD) and the C-terminal functional domain (CTD) are fixed amino acid sequences. The repeat unit array is designed and assembled according to the sequence of the target editing site. The repeat unit is assembled using the Golden Gate method, and commercial companies can be commissioned to assemble the TALE repeat units.
[0061] The L fusion protein of gmtGBE fuses the nickase at the C-terminus of TALE, e.g. Figures 1 to 3 As shown. The present application uses a partial functional domain of the Nt.BspD6I nickase derived from Bacillus. Nt.BspD6I can form a heterodimer with BspD6I (small subunit, 20 kDa) and act as a restriction endonuclease called R.BspD6I 25. The Nt.BspD6I(C) used in the present application for fusion with TALE is only the C-terminal cleavage domain, i.e., 382-604 amino acids, which has a very low chain preference and can cut and produce a nick at the target DNA editing site. The nickase is selected from Nt.BspD6I(C) but is not limited to Nt.BspD6I(C). The present application also provides a variety of nickases, such as MutH nickase and Fok1-Fok1 D450A Nicking enzyme.
[0062] An exonuclease is also fused to the C-terminus of the L fusion protein nickase, and the DNA exonuclease and the above nickase are connected via a 16aa linker, such as Figure 1 As shown. Trex2 exonuclease is selected in this application. Trex2 is a 3'→5' digestion preferred nuclease. The nickase and Trex2 are connected by a 16aa linker. The function of Trex2 is to digest the nicked DNA at the DNA nick produced by the nickase, thereby exposing a short ssDNA fragment at the target DNA editing site. It is worth noting that the selection of exonucleases is not limited to Trex2, and other exonucleases may also be selected to achieve similar effects, such as mExoI exonuclease.
[0063] The DNA glycosylase GDG is fused to the C-terminus of the R fusion protein TALE. Figure 1As shown. The present application configures guanine DNA glycosylase (GDG). The function of GDG is to remove the G base of the ssDNA exposed at the target editing site to generate an apurinic (AP) site. The AP site will be repaired by translesion synthesis (TLS) and / or DNA replication, resulting in base editing from G to Y, such as Figure 1 As shown. The GDG configured in the present application is gMPGV6.3, which contains G163R, N169G, D175R, C178N, S198A, K202A, G203A, S206A, K210A, and K294R mutations. gMPGV6.3 has the function of excising typical G bases, while wild-type MPG can recognize and remove a variety of damaged purine bases, but the rate of recognizing and removing normal G is very low, and the G base excision activity of single-stranded DNA substrates is higher than that of double-stranded DNA substrates.
[0064] Monomer gmtGBE is a single fusion protein that sequentially fuses the above transit peptide, DNA exonuclease, TALE array, DNA nickase and GDG components. The DNA exonuclease is connected to the TALE array via a 48aa linker, and the nickase is connected to GDG via a 16aa linker.
[0065] The present application provides a binary expression vector of the gmtGBE system. The pEF1a-Puro vector is used for the expression of human gmtGBE, and the supporting vectors of the human gmtGBE system include pgmtGBE-hL, pgmtGBE-hR and pgmtGBE-hm, such as Figure 3 As shown. The pgGBEp vector is used for the expression of plant gmtGBE. The supporting vectors of the plant gmtGBE system also include pgmtGBE-L, pgmtGBE-R and pgmtGBE-m, such as Figure 2 shown.
[0066] The expression of human gmtGBE is driven by the human elongation factor EF-1α core promoter. The expression of plant gmtGBE is driven by the rice Ubi promoter (rUbi) and the maize Ubi promoter (ZmUbi), and the terminator is the Nos terminator (NosT). The pEF1a-Puro plasmid vector has a replicon that can be propagated in Escherichia coli, a selection marker ampicillin resistance gene (ampicillin resistance provided by the β-lactamase gene, AmpR), and a eukaryotic cell selection marker PuroR. The pgGBEp plasmid vector has a replicon that can be propagated in Escherichia coli and Agrobacterium, and a selection marker kanamycin resistance gene (Kanamycin resistance provided by the aminoglycoside phosphotransferase gene, KanR).
[0067] The present application provides a method for constructing the above-mentioned base editing system.
[0068] Method for constructing the human gmtGBE system: TALE repeat unit arrays are designed according to the sequences on both sides of the target editing site of the mitochondrial genome of interest, and commercial companies can be commissioned to assemble TALE repeat units. The assembled TALE repeat unit arrays are inserted into the pgmtGBE-hL and pgmtGBE-hR vectors through the BsaI site. The L fusion protein gene fragment of pgmtGBE-hL is released by the KpnI-SpeI restriction endonuclease, and then cloned into the pEF1a-Puro vector through the KpnI-XbaI restriction endonuclease; the R fusion protein expression cassette of pgmtGBE-hR (driven by the EF1a promoter) is released by the EcoRI-XbaI restriction endonuclease, and then cloned into the pEF1a-Puro vector through the EcoRI-NheI restriction endonuclease site. Finally, the pEF1a-Puro vector integrates two expression cassettes of L fusion protein and R fusion protein for cell infection and transformation. For human monomeric gmtGBE, the TALE repeat array is designed according to the sequence on the side of the target editing site of the mitochondrial genome of interest, and the TALE repeat units can be assembled by a commercial company. The assembled TALE repeat unit array is inserted into pgmtGBE-hm through the BsaI site. The pgmtGBE-hm monomeric fusion protein is released by KpnI-SpeI restriction endonucleases, and then cloned into the pEF1a-Puro vector by KpnI-XbaI restriction endonucleases, and the positive clones are used for cell infection and transformation.
[0069] Method for constructing plant gmtGBE system: TALE repeat unit arrays are designed according to the sequences on both sides of the target editing site of the mitochondrial genome of interest, and commercial companies can be commissioned to assemble TALE repeat units. The assembled TALE repeat unit arrays are inserted into pgmtGBE-L and pgmtGBE-R vectors through the BsaI site. pgmtGBE-L clones the L fusion protein gene fragment into the ZmUbi-NosT expression cassette of the pgGBEp vector through the KpnI-SacI restriction endonuclease site; the R fusion protein expression cassette of pgmtGBE-R (driven by rUbi) replaces the toxic protein marker ccdB expression cassette of the pgGBEp vector through the LR Gateway. Finally, the pgGBEp vector integrates two expression cassettes of L fusion protein and R fusion protein for plant genetic transformation. For plant monomeric gmtGBE, TALE repeat unit arrays are designed according to the sequences on both sides of the target editing site of the mitochondrial genome of interest, and commercial companies can be commissioned to assemble TALE repeat units. The assembled TALE repeat unit array was inserted into pgmtGBE-m through the BsaI site. The pgmtGBE-m fusion protein expression cassette (driven by rUbi) replaced the toxic protein marker ccdB of the pgGBEp vector through LR Gateway, and the positive clones were used for plant transformation.
[0070] The present application also provides an application method of the above-mentioned base editing system. After selecting the target position sequence of mitochondrial DNA of plants such as rice and the target position sequence of mitochondrial DNA of humans, TALE repeat units are assembled and the corresponding vector construction is completed. The vector can transform eukaryotic cells, or transform plants through Agrobacterium / gene gun, so that the target site sequence can achieve GY base editing.
[0071] The application method of the base editing system of the present application also includes: extracting the transformed plant or human organelle DNA, then using specific primers for the target to perform PCR amplification, using the PCR product of the organelle DNA to construct a high-throughput second-generation DNA sequencing library, and performing high-throughput second-generation DNA sequencing. Among them, the organelle DNA target of a species includes but is not limited to at least one of the Cob and Cox2 targets.
[0072] The experimental method of this application includes the following steps:
[0073] 1) Construct an expression vector. Design TALE target sequences on both sides of the target base editing site. The previous base at the 5' end of the TALE target sequence must be a T base, and the TALE target sequence length is in the range of 12-24bp. At the same time, the distance between the 3' end of the TALE target sequence and the target base editing site is in the range of 3-20bp for higher editing efficiency. After the TALE target sequence is designed and determined, the TALE repeat unit array is assembled according to the TALE target sequence. Then the TALE repeat unit array is cloned into the corresponding expression vector provided in this application through the BsaI restriction site.
[0074] 2) Plant expression vectors use Agrobacterium to transform plant tissues; while human cell expression vectors transform the cell line HEK293T.
[0075] 3) Genomic DNA extraction and amplification: Extract the genomic DNA of the transformed cells and then perform PCR amplification using specific primers targeting the target editing site.
[0076] 4) High-throughput second-generation DNA sequencing of genomic DNA PCR products. A high-throughput second-generation DNA sequencing library was constructed using genomic DNA PCR products, and high-throughput second-generation DNA sequencing was performed.
[0077] The present application is further described in detail below by specific examples. The following examples are only used to further illustrate the present application and should not be construed as limiting the present application. Unless otherwise specified, the methods for plasmid or strain construction in the present application are all based on the Molecular Cloning Experiment Guide (4th edition).
[0078] Example
[0079] The experimental method includes the following steps:
[0080] 1) Constructing an expression vector: Design TALE target sequences on both sides of the target base editing site. The previous base at the 5' end of the TALE target sequence must be a T base, and the TALE target sequence length is in the range of 12-24bp. At the same time, the distance between the 3' end of the TALE target sequence and the target base editing site is in the range of 3-20bp for higher editing efficiency. After the TALE target sequence is designed and determined, the TALE repeat unit array is assembled according to the TALE target sequence. Then the TALE repeat unit array is cloned into the corresponding expression vector provided in this application through the BsaI restriction site.
[0081] 2) Plant expression vectors use Agrobacterium to transform plant tissues; while human cell expression vectors transform the cell line HEK293T.
[0082] 3) Extraction and amplification of genomic DNA: Extract the genomic DNA of transformed cells and then perform PCR amplification using specific primers for the target editing site.
[0083] 4) High-throughput second-generation DNA sequencing of PCR products of genomic DNA; constructing a high-throughput second-generation DNA sequencing library using PCR products of genomic DNA, and performing high-throughput second-generation DNA sequencing.
[0084] 1. Base editing of the rice Cob gene using the dimorphic plant gmtGBE system
[0085] 1) Reagents
[0086] Primers were synthesized by Sangon Biotech (Shanghai) Co., Ltd. according to conventional methods; plasmid sequencing was entrusted to Sangon Biotech (Shanghai) Co., Ltd.; KpnI, SacI, BsaI restriction endonucleases, DNA ligase (T4 DNAligase), and high-fidelity DNA polymerase were purchased from NEB; LR Gateway enzyme mix was purchased from Thermo Fisher Scientific; kanamycin sulfate and rifampicin were purchased from Beijing Solebao Technology Co., Ltd.; plasmid mini-extraction kit, DNA gel recovery kit and high-efficiency plant genomic DNA extraction kit were purchased from Tiangen Biochemical Technology Co., Ltd.; DB3.1 and Trans1-T1 Escherichia coli competent cells, and EHA105 Agrobacterium competent cells were purchased from Shanghai Weidi Biotechnology Co., Ltd.; vector plasmids pUC-KANA and pCAMBIA1300 were purchased from Sangon Biotechnology (Shanghai) Co., Ltd.; TALE repeat unit arrays were commissioned to Guangzhou Yijin Biotechnology Co., Ltd. for assembly; gene synthesis was commissioned to Yunzhou Biotechnology (Guangzhou) Co., Ltd.; rice genetic transformation experiments were commissioned to Wuhan Boyuan Biotechnology Co., Ltd.; QuickExtractTM genomic DNA extraction reagents and high-throughput DNA second-generation sequencing library construction kit TmSeqChIPLibary Preparation Kit were purchased from Illumina.
[0087] 2) Vector construction
[0088] The pgmtGBE-L, pgmtGBE-R and pgmtGBE-m vectors use the pUC-KANA plasmid as the starting backbone, and the pgGBEp vector uses the pCAMBIA1300 plasmid as the starting backbone. The synthesis and cloning of the rUbi promoter, Nos terminator, aatL, ccdB and other element fragments were all completed by commercial companies.
[0089] 3) TALE target sequence design and assembly
[0090] The left and right TALE repeat unit arrays were designed according to the sequences on both sides of the Cob target editing site of the mitochondrial gene of interest. According to the rules that the four TALE repeat units NI, NG, NN and HD recognize the nucleotides "A", "T", "G" and "C", respectively, a commercial company was commissioned to assemble the TALE repeat units. The assembled TALE repeat unit arrays were inserted into the pgmtGBE-L and pgmtGBE-R vectors through the BsaI site, transformed into Trans1-T1 Escherichia coli, and cultured on kanamycin sulfate plates. The TALE repeat unit arrays of pgmtGBE-L and pgmtGBE-R were sequenced and confirmed by sequencing primers NTD-F and CTD-R.
[0091] Among them, the TALE repeat unit array on the left is the sequence shown in SEQ ID NO.13, the TALE repeat unit array on the right is the sequence shown in SEQ ID NO.14, the sequencing primer NTD-F is the sequence shown in SEQ ID NO.15, and the sequencing primer CTD-R is the sequence shown in SEQID NO.16.
[0092] SEQ ID NO.13: 5'-TGTTTAAGAAGAGAGAATCG-3'
[0093] SEQ ID NO.14: 5'-CACGATAGAAAAGAGAAATG-3'
[0094] SEQ ID NO.15: 5'-CACCACTCCAGTTGGACACAG-3'
[0095] SEQ ID NO.16: 5'-TAGGAACGCGGTGGGATGTG-3'
[0096] The Cob target site editing strand is the sequence shown in SEQ ID NO.25.
[0097] SEQ ID NO.25: 5'-ACTATAAGGAACCAA-3'
[0098] pgmtGBE-L cloned the gene fragment of L fusion protein into the ZmUbi-NosT expression cassette of pgGBEp vector through KpnI-SacI restriction endonuclease site, transformed DB3.1 Escherichia coli, and cultured on kanamycin sulfate plate; then the R fusion protein expression cassette of pgmtGBE-R, driven by rUbi, replaced the toxic protein marker ccdB expression cassette of pgGBEp vector through LR Gateway, transformed Trans1-T1 Escherichia coli, and cultured on kanamycin sulfate plate. Finally, pgGBEp vector integrated two expression cassettes of L fusion protein and R fusion protein, recorded as pgGBEp-Cob, for plant genetic transformation.
[0099] Among them, the transit peptide is a plant mitochondrial transit peptide, that is, the sequence shown in SEQ ID NO.1, the N-terminal functional domains of TALE-L and TALE-R are the sequences shown in SEQ ID NO.3, the C-terminal functional domains of TALE-L and TALE-R are the sequences shown in SEQ ID NO.4, the BspD6I nickase is the sequence shown in SEQ ID NO.5, the Trex2 exonuclease is the sequence shown in SEQ ID NO.8, and the BspD6I nickase and Trex2 exonuclease are connected by a 16aa linker, and the 16aa linker is the sequence shown in SEQ ID NO.11.
[0100] The DNA glycosylase in this example is an engineered mutant of gMPGV6.3, and its sequence is shown in SEQ ID NO.12.
[0101] Among them, in addition to BspD6I nickase, MutH nickase or Fok1-Fok1 D450A Nicking enzyme, MutH nicking enzyme is the sequence shown in SEQ ID NO.6, Fok1-Fok1 D450A The nicking enzyme is the sequence shown in SEQ ID NO. 7. In addition to Trex2 exonuclease, mExoI exonuclease can also be used, and the mExoI exonuclease is the sequence shown in SEQ ID NO. 9.
[0102] SEQ ID NO.1:
[0103] ARRVAARARARFGGVPRSEGTIQDRARVGSGGAEDALDVFDELLRRGIGAPIRSLNGALADVARDNPAAAVSRFN
[0104] SEQ ID NO.3:
[0105] DLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGHGFTHAHIVALSQHPAALGTVAVTYQDIIRALPEATHEDIVGVGKQWSGARALEALLTEAGELRGPPLQLDTGQLLKIAKRGGVTAVEAVH
[0106] SEQ ID NO.4:RPALDAVKKGLPHAPELIRRINRRIPERTSHRVP
[0107] SEQ ID NO.5:
[0108] RQLEEVIDLLEVYHEKKNVIEEKIKARFIANKNTVFEWLTWNGFIILGNALEYKNNFVIDEELQPVTHAAGNQPDMEIIYEDFIVLGEVTTSKGATQFKMESEPVTRHYLNKKKELEKQGVEKELYCLFIAPEINKNTFEEFMKYNIVQNTRIIPLSLKQFNMLLMVQKKLIEKGRRLSSYDIKNLMVSLYRTTIECERKYTQIKAGLEETLNNWVVDKEVRF
[0109] SEQ ID NO.6:
[0110] MSQPRPLLSPPETEEQLLAQAQQLSGYTLGELAALVGLVTPENLKRDKGWIGVLLEIWLGASAGSKPEQDFAALGVELKTIPVDSLGRPLETTFVCVAPLTGNSGVTWETSHVRHKLKRVLWIPVEGERSIPLAQRRVGSPLLWSPNEEEDRQLREDWEELMDMIVLGQVERITARHGEYLQIRPKAANAKALTEAIGARGERILTLPRGFYLKKNFTSALLARHFLIQ
[0111] SEQ ID NO.7:
[0112] FKQLVKSELEEKKSELRHKLKYVPHEYIELIEIARNSTQDRILEMKVMEFFMKVYGYRGKHLGGSRKPDGAIYTVGSPIDYGVIVDTKAYSGGYNLPIGQADEMQRYVEENQTRNKHINPNEWWKVYPSSVTEFKLFVSGHFKGNYKAQLTRLNHITNCNGAVLSVEELLIGMEKIGAGTLTLEEVRRKFNNGEINFSGGSSGGSSGSETPGTSESATPESSGGSSGGSSGSETPGTSESATPESQLVKSELEEKKSELRHKLKYVPHEYIELIEIARNSTQDRILEMKVMEFFMKVYGYRGKHLGGSRKPAGAIYTVGSPIDYGVIVDTKAYSGGYNLPIGQADEMQRYVEENQTRNKHINPNEWWKVYPSSVTEFKLFVSGHFKGNYKAQLTRLNHITNCNGAVLSVEELLIGMEKIGAGTLTLEEVRRKFNNGEINF
[0113] SEQ ID NO.8:
[0114] MSEPPRAETFVFLDLEATGLPNMDPEIAEISLFAVHRSSLENPERDDSGSLVLPRWLDKLTLCMCPERPFTAKASEITGLSSESLMHCGKAGFNGAVVRTLQGFLSRQEGPICLVAHNGFDY DFPLLCTELQRLGAHLPQDTVCLDTLPLARGLDRAHSHGTRAQGRKSYSLASLFHRYFQAEPSAAHSAEGDVHTLLLIFLHRAPELLAWADEQARSWAHIEPMYVPPDGPSLEA
[0115] SEQ ID NO.9:
[0116] MGIQGLLQFIQEASEPVNVKKYKGQAVAVDTYCWLHKGAIACAEKLAKGEPTDRYVGFCMKFVNMLLSYGVKPILIFDGCTLPSKKEVERSRRERRQSNLLKGKQLLREGKVSEARDCFARSINITHAMAHKVIKAARALGVDCLVAPYEADAQLAYLNKAGIVQAVITEDSDLLAFGCKKVILKMDQFGNGLEVDQARLGMCKQLGDVFTEEKFRYMCILSGCDYLASLRGIGLAKACKVLRLANNPDIVKVIKKIGHYLRMNITVPEDYITGFIRANNTFLYQLVFDPIQRKLVPLNAYGDDVNPETLTYAGQYVGDSVALQIALGNRDVNTFEQIDDYSPDTMPAHSRSHSWNEKAGQKPPGTNSIWHKNYCPRLEVNSVSHAPQLKEKPSTLGLKQVISTKGLNLPRKSCVLKRPRNEALAEDDLLSQYSSVSKKIKENGCGDGTSPNSSKMSKSCPDSGTAHKTDAHTPSKMRNKFATFLQRRNEESGAVVVPGTRSRFFCSSQDFDNFIPKKESGQPLNETVATGKATTSLLGALDCPDTEGHKPVDANGTHNLSSQIPGNAAVSPEDEAQSSETSKLLGAMSPPSLGTLRSCFSWSGTLREFSRTPSPSASTTLQQFRRKSDPPACLPEASAVVTDRCDSKSEMLGETSQPLHELGCSSRSQESMDSSCGLNTSSLSQPSSRDSGSEESDCNNKSLDNQGEQNSKQHLPHFSKKDGLRRNKVPGLCRSSSMDSFSTTKIKPLVPARVSGLSKKSGSMQTRKHHDVENKPGLQTKISELWKNFGFKKDSEKLPSCKKPLSPVKDNIQLTPETEDEIFNKPECVRAQRAIFH
[0117] SEQ ID NO.11:SGSETPGTSESATPES
[0118] SEQ ID NO.12:
[0119] VTPALQMKKPKQFCRRMGQKKQRPARAGQPHSSSDAAQAPAEQPHSSSDAAQAPCPRERCLGPPTTPGPYRSIYFSSPKGHLTRLGLEFFDQPAVPLARAFLGQVLVRRLPNGTELRGRIVETEAYLGPEDEAAHSRGGRQTPRNRGM FMKPGTLYVYIIYRMYFCMGISSQGRGANVLLRALEPLEGLETMRQLRATLRAATAARVLADRELCSGPSKLCQALAINKSFDQRDLAQDEAVWLERGPLEPSEPAVVAAARVGVGHAGEWARKPLRFYVRGSPWVSVVDRVAERDTQA
[0120] 4) Rice genetic transformation
[0121] Extract pgGBEp-Cob positive clone plasmid, take 50ng to transform EHA105 Agrobacterium competent cells, spread on LB bacterial culture plate, containing 50μg / mL kanamycin sulfate and 50μg / mL rifampicin, and culture at 28℃ for 36h to obtain single colonies. Wuhan Boyuan Biotechnology Co., Ltd. was entrusted with the positive Agrobacterium colony to carry out rice callus infection and subsequent resistant callus (screening antibiotic is hygromycin) and callus regeneration to obtain transgenic plants.
[0122] 5) Identification of transgenic plants and analysis of target site gene editing efficiency
[0123] The leaves of the transgenic plants were taken and the total genomic DNA was extracted using an efficient plant genomic DNA extraction kit. Primers ZmUbi-F and NTD-R were used to identify whether the transgenic plants were positive, i.e., containing the pgGBEp-Cob transgenic fragment. The mitochondrial DNA fragment containing the target site sequence was amplified using primers Cob-F and Cob-R to analyze the efficiency of gene editing at the target site.
[0124] Among them, ZmUbi-F is the sequence shown in SEQ ID NO.17, NTD-R is the sequence shown in SEQ ID NO.18, PsbA-F is the sequence shown in SEQ ID NO.19, and PsbA-R is the sequence shown in SEQ ID NO.20.
[0125] SEQ ID NO.17: 5'-TTTAGCCCTGCCTTCATACGC-3'
[0126] SEQ ID NO.18: 5'-CTGGCTGAGAGCAACGATGTG-3'
[0127] SEQ ID NO.19: 5'-ACGCTGTTGAAAGCTAGATCC-3'
[0128] SEQ ID NO.20: 5'-AGCTTAAGAAACCGGCAGTT-3'
[0129] The PCR system is as follows:
[0130] Phusion (NEB, M0535L) 1 μL; 5× buffer (NEB, B0518S) 4 μL; Forward Primer (5 μM) 1 μL; Reverse Primer (5 μM) 1 μL; Template 50ng; RNase-free water was added to 50 μL.
[0131] The PCR program was as follows: 95°C, 2 min; then 33 cycles: 95°C, 15 sec, 60°C, 30 sec, 72°C, 1 min; after the cycle, 72°C, 3 min.
[0132] The PCR products of Cob-F and Cob-R primers were used to prepare high-throughput sequencing libraries for DNA-seq. Specifically, the concentration and purity of PCR products were first checked using Qubit Fluorometer and Aglient Bioanalyzer 2100 respectively; for samples that passed the quality inspection, different PCR products were added with different biotin-labeled barcodes using the Illumina official kit TruSeq ChIP Sample Preparation Kit, and PCR amplification and enrichment were performed to complete the preparation of sequencing libraries, and the concentration and fragment size of the constructed libraries were checked; finally, high-throughput sequencing was performed using the Illumina HiSeq 2500 sequencer.
[0133] The results of high-throughput sequencing showed that the efficiency of converting the two target G bases at the Cob target site into T bases reached 71% and 74%, respectively, and the efficiency of converting into C bases reached 23% and 19%, respectively.
[0134] 2. Base editing of the rice Cob gene using the monomeric plant gmtGBE system
[0135] 1) Reagents
[0136] Same as “1. Base editing of rice mitochondrial Cob gene using the diploid plant gmtGBE system”.
[0137] 2) Vector construction
[0138] Same as “1. Base editing of rice mitochondrial Cob gene using the diploid plant gmtGBE system”.
[0139] 3) TALE target sequence design and assembly
[0140] The TALE repeat unit array is designed according to the sequence on one side of the target editing site of the mitochondrial gene Cob of interest. In this example, the left TALE repeat unit array with the same sequence as that shown in SEQ ID NO.13 is specifically designed as the TALE array of the monomer fusion protein. According to the rules that the four TALE repeat units NI, NG, NN and HD recognize the nucleotides "A", "T", "G" and "C" respectively, a commercial company is commissioned to assemble the TALE repeat units. The assembled TALE repeat unit arrays are respectively inserted into the pgmtGBE-m vector (transformed into Trans1-T1 Escherichia coli and cultured on kanamycin sulfate plates) through the BsaI site. The TALE repeat unit array of pgmtGBE-m can be sequenced and confirmed by sequencing primers NTD-F and CTD-R.
[0141] The monomer fusion protein is sequentially a transit peptide of the sequence shown in SEQ ID NO.1, a Trex2 exonuclease of the sequence shown in SEQ ID NO.8, an N-terminal functional domain of the sequence shown in SEQ ID NO.3, a left TALE repeat unit array of the sequence shown in SEQ ID NO.13, a C-terminal functional domain of the sequence shown in SEQ ID NO.4, a BspD6I nickase of the sequence shown in SEQ ID NO.5, and an engineered mutant of gMPGV6.3 of the sequence shown in SEQ ID NO.12. In addition, the Trex2 exonuclease and the N-terminal functional domain are connected by a 48aa linker, and the BspD6I nickase and the engineered mutant of gMPGV6.3 are connected by a 16aa linker, the 48aa linker is the sequence shown in SEQ ID NO.10, and the 16aa linker is the sequence shown in SEQ ID NO.11.
[0142] SEQ ID NO.10:
[0143] SGGSSGGSSGSETPGTSESATPESSGGSSGGSSGSETPGTSESATPES
[0144] The monomer fusion protein expression cassette of pgmtGBE-m (driven by rUbi) replaced the toxic protein marker ccdB expression cassette of the pgGBEp vector (transformed into Trans1-T1 Escherichia coli and cultured on kanamycin sulfate plates) through LR Gateway, and the positive clone was recorded as pgGBEp-Cob-m for plant genetic transformation.
[0145] 4) Rice genetic transformation
[0146] The rice genetic transformation of pgGBEp-Cob-m is the same as “1. Base editing of rice mitochondrial Cob gene using the diploid plant gmtGBE system”.
[0147] 5) Identification of transgenic plants and analysis of target site gene editing efficiency
[0148] The methods for transgenic plant identification and target site gene editing efficiency analysis are the same as those in “I. Base editing of rice mitochondrial Cob gene using the disomal plant gmtGBE system”.
[0149] The results of high-throughput sequencing showed that the efficiency of converting the two target G bases at the Cob target site into T bases reached 68% and 70%, respectively, and the efficiency of converting into C bases reached 20% and 17%, respectively.
[0150] 3. Base editing of the mitochondrial Cox2 gene in human cells using the dimeric human gmtGBE system
[0151] 1. Experimental Materials
[0152] 1) Reagents
[0153] Primers were synthesized by Sangon Biotech (Shanghai) Co., Ltd. according to conventional methods; plasmid sequencing was commissioned by Sangon Biotech (Shanghai) Co., Ltd.; TALE repeat unit array was commissioned by Guangzhou Yijin Biotechnology Co., Ltd. for assembly; vector plasmid pUC-KANA was purchased from Sangon Biotech (Shanghai) Co., Ltd., and vector plasmid pLV3-CMV was purchased from Yunzhou Biotechnology (Guangzhou) Co., Ltd.; TALE repeat unit array was commissioned by Guangzhou Yijin Biotechnology Co., Ltd. for assembly; gene synthesis was commissioned by Yunzhou Biotechnology (Guangzhou) Co., Ltd.; EcoRI, SpeI, XbaI, NheI, BsaI restriction endonucleases, DNA ligase (T4 DNAligase) high-fidelity DNA polymerase were purchased from NEB; DB3.1 and Trans1-T1 Escherichia coli competent cells were purchased from Shanghai Weidi Biotechnology Co., Ltd.; ampicillin and kanamycin sulfate were purchased from Beijing Solebow Technology Co., Ltd.; EndoFree plasmid kit was purchased from Qiagen; GeneJET gel extraction kit was purchased from ThermoScientific; mycoplasma detection kit was purchased from TransGen Biotech Company; 48-well poly-d-lysine coated plates were purchased from Corning; Polyplus Transfection cell transfection kit was purchased from ANNORON; proteinase K and 1×Dulbecco's PBS were purchased from Thermo Fisher Scientific; QuickExtractTM genomic DNA extraction reagent and high-throughput DNA second-generation sequencing library construction kit TmSeqChIPLibary Preparation Kit were purchased from Illumina.
[0154] 2) Cell line: HEK293T (purchased from the Cell Bank of the Chinese Academy of Sciences)
[0155] 2. Experimental Methods
[0156] 1) Vector construction
[0157] The pgmtGBE-hL, pgmtGBE-hR and pgmtGBE-hm vectors use the pUC-KANA plasmid as the starting backbone, and the pEF1a-Puro vector uses the pLV3-CMV plasmid as the starting backbone. The synthesis and cloning of element fragments such as the EF-1α promoter, Cox8 transit peptide, and ccdB were all completed by commercial companies.
[0158] 2) TALE target sequence design and assembly
[0159] According to the sequences on both sides of the target editing site of the mitochondrial gene Cox2 of interest, the left TALE and right TALE repeat unit arrays were designed respectively. According to the rules that the four TALE repeat units NI, NG, NN and HD recognize the nucleotides "A", "T", "G" and "C", respectively, the TALE repeat units were commissioned to be assembled by a commercial company. The pgmtGBE-hL and pgmtGBE-hR vectors were propagated by DB3.1 Escherichia coli, and plasmid DNA was extracted using a plasmid kit. The assembled TALE repeat unit arrays were inserted into the pgmtGBE-hL and pgmtGBE-hR vectors (transformed into Trans1-T1 Escherichia coli and cultured on kanamycin sulfate plates) through the BsaI site. The TALE repeat unit arrays of pgmtGBE-hL and pgmtGBE-hR can be sequenced and confirmed by sequencing primers NTD-F and CTD-R. Among them, the sequencing primers NTD-F and CTD-R are the same as those in "I. Base editing of rice Cob gene using the disomal plant gmtGBE system".
[0160] The L fusion protein gene fragment of pgmtGBE-hL was released by KpnI-SpeI restriction endonuclease, and then cloned into the pEF1a-Puro vector by KpnI-XbaI restriction endonuclease; the R fusion protein expression cassette of pgmtGBE-hR (driven by EF1a promoter) was released by EcoRI-XbaI restriction endonuclease, and then cloned into the pEF1a-Puro vector through EcoRI-NheI restriction endonuclease site. Finally, the pEF1a-Puro vector integrated the two expression cassettes of L fusion protein and R fusion protein, recorded as pEF1a-Cox2, and used for cell infection and transformation.
[0161] Among them, the TALE repeat unit array on the left is the sequence shown in SEQ ID NO.21, and the TALE repeat unit array on the right is the sequence shown in SEQ ID NO.22.
[0162] SEQ ID NO.21: 5'-CCTATATATCTTAATGGCAC-3'
[0163] SEQ ID NO.22: 5'-AGGGGAAGTAGCGTCTTGTA-3'
[0164] The Cox2 target site editing strand is the sequence shown in SEQ ID NO.26.
[0165] SEQ ID NO.26: 5'-ACCTACTTGCGCTGCAT-3'
[0166] The Cox8 transit peptide is the sequence shown in SEQ ID NO.2. The N-terminal functional domain, C-terminal functional domain, BspD6I nickase, Trex2 exonuclease, and the connecting linker of BspD6I nickase and Trex2 exonuclease of TALE-L and TALE-R are all the same as "1. Base editing of rice mitochondrial Cob gene using the diploid plant gmtGBE system".
[0167] SEQ ID NO.2:SVLTPLLLRGLTGSARRLPVPRAKIHSL
[0168] 3) Eukaryotic cell transfection
[0169] The pEF1a-Cox2 plasmid for transfection of HEK293T cell line was extracted and purified using EndoFree Plasmid Kit (Qiagen).
[0170] HEK293T cells were cultured in DMEM (Gibco) supplemented with 10% (vol / vol) fetal bovine serum (FBS, Gibco) and 1% (vol / vol) penicillin-streptomycin (Gibco) in a 5% CO 2 All cells were routinely tested for mycoplasma contamination using a mycoplasma detection kit (TransGen Biotech). A total of 40,000 cells per well were seeded into a 48-well poly-d-lysine coated plate without antibiotics. After 16-24 hours, HEK293T cells were transfected with 1 μL jetPRIME transfection reagent (Polyplus Transfection Kit) and 400 ng pEF1a-Cox2 plasmid per well to a cell confluence of 60-80%. Cells were washed with PBS 72 hours after transfection and DNA was extracted.
[0171] 4) Genomic DNA extraction and PCR amplification
[0172] After washing the cells once with 1× Dulbecco's PBS, genomic DNA was extracted by adding 100 μL of freshly prepared lysis buffer (10 mM Tris-HCl (pH 8.0), 0.05% SDS, and 25 μg / mL proteinase K) directly to the 48-well culture. The mixture was incubated at 37°C for 60 minutes and then at 80°C for 20 minutes.
[0173] The extracted genomic DNA was amplified by PCR using the following primers Cox-hF and Cox-hR, and the PCR product was recovered by gel excision using the GeneJET gel extraction kit according to the reagent operating instructions for subsequent construction of a high-throughput second-generation DNA sequencing library. Wherein, Cox-hF is the sequence shown in SEQ ID NO.23, and Cox-hR is the sequence shown in SEQ ID NO.24.
[0174] SEQ ID NO.23: 5'-CCTGGAGTGACTATATGGATGC-3'
[0175] SEQ ID NO.24: 5'-GCGATGAGGACTAGGATGATG-3'
[0176] Amplify genomic DNA using the following PCR system:
[0177] Phusion (NEB, M0535L) 1μL; 5×buffer (NEB, B0518S) 4μL; Forward Primer (5μM) 1μL; Reverse Primer (5μM) 1μL; Template 10ng; RNase-free water was added to 50μL.
[0178] The PCR program is as follows:
[0179] 95℃, 2min; then enter 30 cycles: 95℃, 15sec, 55℃, 15sec, 72℃, 30sec; after the cycle, 72℃, 3min.
[0180] 5) High-throughput second-generation DNA sequencing
[0181] The PCR products were used to prepare high-throughput sequencing libraries for DNA-seq. Specifically, the concentration and purity of the PCR products were first checked using Qubit Fluorometer and Aglient Bioanalyzer 2100 respectively; the samples that passed the quality inspection were then fragmented using Covaris S220 ultrasonic DNA crusher; then, different PCR products were added with different biotin-labeled barcodes using the Illumina official kit TruSeq ChIP Sample Preparation Kit, and PCR amplification and enrichment were performed to complete the preparation of the sequencing library, and the concentration and fragment size of the constructed library were checked; finally, the Illumina HiSeq 2500 sequencer was used for high-throughput sequencing.
[0182] The results of high-throughput sequencing showed that the efficiency of converting the three target G bases at the Cox2 target site into T bases was 62%, 70% and 77%, respectively, and the efficiency of converting into C bases was 23%, 25% and 17%, respectively.
[0183] 4. Base editing of the mitochondrial Cox2 gene in human cells using the monomeric human gmtGBE system
[0184] 1) Reagents and cell lines
[0185] Same as “3. Base editing of the mitochondrial Cox2 gene in human cells using the dimeric human gmtGBE system”.
[0186] 2) Vector construction
[0187] Same as “3. Base editing of the mitochondrial Cox2 gene in human cells using the dimeric human gmtGBE system”.
[0188] 3) TALE target sequence design and assembly
[0189] According to the sequence on one side of the target editing site of the mitochondrial gene Cox2 of interest, the TALE repeat unit array is designed. In this example, the left TALE repeat unit array with the same sequence as that shown in SEQ ID NO.21 is specifically designed as the TALE array of the monomer fusion protein. According to the rules that the four TALE repeat units NI, NG, NN and HD recognize the nucleotides "A", "T", "G" and "C", respectively, a commercial company is commissioned to assemble the TALE repeat units. The assembled TALE repeat unit arrays are inserted into the pgmtGBE-hm vector (transformed into Trans1-T1 Escherichia coli and cultured on kanamycin sulfate plates) through the BsaI site. The TALE repeat unit array of pgmtGBE-hm can be sequenced and confirmed by sequencing primers NTD-F and CTD-R.
[0190] The monomer fusion protein is sequentially a transit peptide of the sequence shown in SEQ ID NO.2, a Trex2 exonuclease of the sequence shown in SEQ ID NO.8, an N-terminal functional domain of the sequence shown in SEQ ID NO.3, a left TALE repeat unit array of the sequence shown in SEQ ID NO.21, a C-terminal functional domain of the sequence shown in SEQ ID NO.4, a BspD6I nickase of the sequence shown in SEQ ID NO.5, and an engineered mutant of gMPGV6.3 of the sequence shown in SEQ ID NO.12. In addition, the Trex2 exonuclease and the N-terminal functional domain are connected by a 48aa linker, and the BspD6I nickase and the engineered mutant of gMPGV6.3 are connected by a 16aa linker, the 48aa linker is the sequence shown in SEQ ID NO.10, and the 16aa linker is the sequence shown in SEQ ID NO.11.
[0191] The pgmtGBE-hm monomer fusion protein was released by KpnI-SpeI restriction endonuclease, and then cloned into the pEF1a-Puro vector by KpnI-XbaI restriction endonuclease. The positive clone was recorded as pEF1a-Cox2m and used for cell infection and transformation.
[0192] 3) Eukaryotic cell transfection
[0193] Same as “3. Base editing of the mitochondrial Cox2 gene in human cells using the dimeric human gmtGBE system”.
[0194] 4) Genomic DNA extraction and PCR amplification
[0195] Same as “3. Base editing of the mitochondrial Cox2 gene in human cells using the dimeric human gmtGBE system”.
[0196] 5) High-throughput second-generation DNA sequencing
[0197] Same as “3. Base editing of the mitochondrial Cox2 gene in human cells using the dimeric human gmtGBE system”.
[0198] The results of high-throughput sequencing showed that the efficiency of converting the three target G bases at the Cox2 target site into T bases was 60%, 67% and 73%, respectively, and the efficiency of converting into C bases was 22%, 21% and 15%, respectively.
[0199] The above test results show that the guanine base editor of the present application, independent of deaminase, can edit the genomic guanine base from G to Y, that is, from G to T or G to C, in the mitochondria of plants and animals. This fills the gap in the technology and tools for guanine base editing in the genome of eukaryotic organelles and expands the targeting range of base editors.
[0200] The above contents are further detailed descriptions of the present application in combination with specific implementation methods, and it cannot be determined that the specific implementation of the present application is limited to these descriptions. For ordinary technicians in the technical field to which the present application belongs, several simple deductions or substitutions can be made without departing from the concept of the present application.
Claims
1. A DNA glycosylase composition, Features: The DNA glycosylase composition is a monomeric fusion protein or a dimeric fusion protein; The monomer fusion protein sequentially fuses a transit peptide, a DNA exonuclease, a TALE array, a DNA nickase, and a guanine DNA glycosylase; The dimeric fusion protein includes an L fusion protein and an R fusion protein, wherein the L fusion protein sequentially fuses a transit peptide, TALE-L, a DNA nickase, and a DNA exonuclease, and the R fusion protein sequentially fuses a transit peptide, TALE-R, and a guanine DNA glycosylase; The transit peptide is used to guide the guanine base editor to the corresponding organelle to achieve G base editing; The TALE array, TALE-L and TALE-R are all composed of an N-terminal functional domain, a repeating unit array and a C-terminal functional domain, wherein the repeating unit array is a specific binding sequence designed for the target sequence.
2. The DNA glycosylase composition according to claim 1, Features: In the monomeric fusion protein and the dimeric fusion protein, the transit peptide is a plant mitochondrial transit peptide or an animal mitochondrial transit peptide; Preferably, the plant mitochondrial transit peptide is derived from the rice Rf1b cytoplasmic male sterility restorer gene transit peptide; Preferably, the animal mitochondrial transit peptide is a human mitochondrial transit peptide, which is a mitochondrial transit peptide derived from the human COX8A gene.
3. The DNA glycosylase composition according to claim 2, Features: The plant mitochondrial transit peptide is the sequence shown in SEQ ID NO.1; Preferably, the animal mitochondrial transit peptide is the sequence shown in SEQ ID NO.
2.
4. The DNA glycosylase composition according to claim 1, Features: In the monomeric fusion protein and the dimeric fusion protein, the N-terminal functional domain is the sequence shown in SEQ ID NO.3; Preferably, the C-terminal functional domain is the sequence shown in SEQ ID NO.
4.
5. The DNA glycosylase composition according to claim 1, Features: In the monomeric fusion protein and the dimeric fusion protein, the DNA nickase is BspD6I nickase, MutH nickase or Fok1-Fok1 D450A Nicking enzyme; Preferably, the BspD6I nickase is the sequence shown in SEQ ID NO.5; Preferably, the MutH nickase is the sequence shown in SEQ ID NO.6; Preferably, the Fok1-Fok1 D450A The nickase is the sequence shown in SEQ ID NO.7; Preferably, in the monomeric fusion protein and the dimeric fusion protein, the DNA exonuclease is Trex2 exonuclease or mExoI exonuclease; Preferably, the Trex2 exonuclease is the sequence shown in SEQ ID NO.8; Preferably, the mExoI exonuclease is the sequence shown in SEQ ID NO.9; Preferably, in the monomeric fusion protein, the DNA exonuclease and the TALE array are connected via a 48aa linker; Preferably, the 48aa linker is the sequence shown in SEQ ID NO.10; Preferably, in the monomeric fusion protein, the DNA nickase and the guanine DNA glycosylase are connected via a 16aa linker; Preferably, in the L fusion protein, the DNA nickase and the DNA exonuclease are connected via a 16aa linker; Preferably, the 16aa linker is the sequence shown in SEQ ID NO.
11.
6. The DNA glycosylase composition according to claim 1, Features: The guanine DNA glycosylase is an engineered mutant of gMPGV6.3, and its mutation information is G163R, N169G, D175R, C178N, S198A, K202A, G203A, S206A, K210A and K294R; Preferably, the guanine DNA glycosylase is the sequence shown in SEQ ID NO.
12.
7. An expression vector for expressing the DNA glycosylase composition according to any one of claims 1 to 6.
8. The expression vector according to claim 7, Features: When the transit peptide of the DNA glycosylase composition is a plant mitochondrial transit peptide, the expression vector is driven by a rice Ubi promoter and / or a corn Ubi promoter; when the transit peptide of the DNA glycosylase composition is an animal mitochondrial transit peptide, the expression vector is driven by a human elongation factor EF-1α core promoter; Preferably, the expression vector has a replicon that propagates in Escherichia coli and / or Agrobacterium; Preferably, the expression vector has a selection marker; Preferably, the selection marker is a kanamycin resistance gene or an ampicillin resistance gene.
9. Use of the DNA glycosylase composition according to any one of claims 1 to 6 or the expression vector according to claim 7 or 8 in preparing a reagent for mitochondrial genome editing.
10. Use of the DNA glycosylase composition according to any one of claims 1 to 6 or the expression vector according to claim 7 or 8 in the preparation of breeding reagents or gene therapy reagents.
Citation Information
Patent Citations
Base editor and application thereof
CN117384885A
Recombinant protein capable of realizing wide-range adenine base editing on organelle DNA, nucleic acid, vector and application
CN118165122A
